DCF — BAYSTATE MEDICAL CENTER
Enterprise Value: $-3.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.3B
Enterprise Value
$-1.0B
PV of Cash Flows
$-2.3B
PV of Terminal Value
$-3.7B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.5B | $-218.2M | -15.0% | $-281.8M | $-256.2M |
| Year 2 | $1.5B | $-209.2M | -14.0% | $-274.8M | $-227.1M |
| Year 3 | $1.6B | $-199.6M | -13.0% | $-267.1M | $-200.7M |
| Year 4 | $1.6B | $-197.3M | -12.0% | $-266.9M | $-182.3M |
| Year 5 | $1.7B | $-199.0M | -12.0% | $-270.6M | $-168.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.5B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15014209473654686
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5